The post NICE issues draft ‘no’ on first quadruplet combination for England and Wales appeared first on Myeloma UK.
Recent Content
- CAR T-cells in multiple myeloma: the race to the start line
- Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemia
- Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
- (no title)
- (no title)
- (no title)
- Trial offers ‘a light’ for patients with extramedullary myeloma
- Expanding access to care in multiple myeloma
- (no title)
- Vyriad targets 2026 clinical trial for new experimental cell therapy VV169